A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2001

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Chronic Hepatitis B
Interventions
DRUG

Entecavir

Trial Locations (35)

10003

Local Investigator, New York

10029

Local Investigator, New York

10032

Local Investigator, New York

11030

Local Investigator, Manhasset

14642

Local Investigator, Rochester

15213

Local Investigator, Pittsburgh

19104

Local Investigator, Philadelphia

22031

Local Investigator, Fairfax

23249

Local Investigator, Richmond

28203

Local Investigator, Charlotte

30309

Local Investigator, Atlanta

30322

Local Investigator, Atlanta

33136

Local Investigator, Miami

35294

Local Investigator, Birmingham

37211

Local Investigator, Nashville

44125

Local Investigator, Cleveland

48073

Local Investigator, Royal Oak

48109

Local Investigator, Ann Arbor

52242

Local Investigator, Iowa City

55114

Local Investigator, Saint Paul

60622

Local Investigator, Chicago

75235

Local Investigator, Dallas

85724

Local Investigator, Tucson

90048

Local Investigator, Los Angeles

90505

Local Investigator, Torrance

92037

Local Investigator, La Jolla

92868

Local Investigator, Orange

94115

Local Institution, San Francisco

94304

Local Investigator, Palo Alto

96820

Local Investigator, Honolulu

98195

Local Investigator, Seattle

06030

Local Investigator, Farmington

02111

Local Investigator, Boston

01655

Local Investigator, Worcester

02908

Investigator Meeting, Providence

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY